Refine by
Tissue Damage Suppliers In Singapore
2 companies found
based inMelbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...
Revascor is a Phase 3 product candidate being developed as a treatment for both advanced and end-stage chronic heart failure ...
based inSingapore City, SINGAPORE
Genesis MedTech is committed to transforming healthcare accessibility for people who need healthcare innovation most, safeguarding the health of patients and being a catalyst of change for practitioners, wherever they are. We can do it because of ...
The absorbable single-strand suture of polydioxanone (PDO) can support the wound for more than 6 weeks, with little tissue reaction and no foreign body residue. The tension attenuation of PDO material is not affected by the alkaline ...